Newsbenzinga
These Analysts Boost Their Forecasts On MiniMed Group Following Q1 Sales Results
· Published
Article summary
MiniMed Group beat Q1 sales estimates with 16.6% growth to $843M; shares rose 7.1% as analysts raised price targets to $26-$28.
An excerpt from the original article.
Comments —
Loading comments…